This prestigious award highlights an outstanding individual who has had a significant positive impact in the reagent sector.

We are delighted to announce the well-deserved winner for the Significant Individual Impact award: Dr. Giovanna Roncador, head of the Monoclonal Antibodies Unit/Biotechnology Programme at the Spanish National Cancer Research Center (CNIO), and Founder and Chair of EuroMabNet.

Professor Roncador is a highly impressive individual focused on antibody production and technology transfer. Her commitment to producing quality reagents, international collaboration in the sector and consistent innovation is evident in her work, and is truly remarkable.

Some career highlights include:

• The production of over 150 high quality mAbs by her unit, many for use in the research and diagnosis of cancer
• Successful licensing of quality antibodies to many global suppliers
• 80 research articles published in peer-reviewed international journals
• Founder and chair of EuroMabNet, the first European non-profit organisation of multidisciplinary academic laboratories involved in the generation or use of validated monoclonal antibodies

Dr Andrew Chalmers, CEO and founder of CiteAb said ‘Giovanna really is an outstanding example of how an individual can create measurable and significant impact in the research reagent sector. She has produced quality reagents, coordinated sector initiatives and undertaken fascinating research. Anybody who has met Giovanna can not help but be bowled over by her enthusiasm for everything antibody. I am sure many in the sector will be delighted with her well deserved win.’